These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33482308)

  • 21. Opioids for cancer pain: A growing quandary: Opioid prescriptions for cancer-related pain are facing greater scrutiny amid the nation's spiraling epidemic.
    Nelson B
    Cancer Cytopathol; 2019 Jun; 127(6):347-348. PubMed ID: 32491266
    [No Abstract]   [Full Text] [Related]  

  • 22. Opioid receptors beyond pain control: The role in cancer pathology and the debated importance of their pharmacological modulation.
    Carli M; Donnini S; Pellegrini C; Coppi E; Bocci G
    Pharmacol Res; 2020 Sep; 159():104938. PubMed ID: 32504831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HDAC inhibitor TSA ameliorates mechanical hypersensitivity and potentiates analgesic effect of morphine in a rat model of bone cancer pain by restoring μ-opioid receptor in spinal cord.
    Hou X; Weng Y; Ouyang B; Ding Z; Song Z; Zou W; Huang C; Guo Q
    Brain Res; 2017 Aug; 1669():97-105. PubMed ID: 28559159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying appropriate outcomes to help evaluate the impact of the Canadian Guideline for Safe and Effective Use of Opioids for Non-Cancer Pain.
    Allen M; Sproule B; MacDougall P; Furlan A; Murphy L; Borg Debono V; Buckley N
    BMC Anesthesiol; 2020 Jan; 20(1):6. PubMed ID: 31910806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morphine as a treatment of cancer-induced pain-is it safe? A review of in vivo studies and mechanisms.
    Brinkman D; Wang JH; Redmond HP
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Nov; 391(11):1169-1178. PubMed ID: 30232510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pain Management in the Era of the Opioid Crisis.
    Bruera E; Del Fabbro E
    Am Soc Clin Oncol Educ Book; 2018 May; 38():807-812. PubMed ID: 30231341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biased Opioid Antagonists as Modulators of Opioid Dependence: Opportunities to Improve Pain Therapy and Opioid Use Management.
    Sadee W; Oberdick J; Wang Z
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32932935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current strategies toward safer mu opioid receptor drugs for pain management.
    Ehrlich AT; Kieffer BL; Darcq E
    Expert Opin Ther Targets; 2019 Apr; 23(4):315-326. PubMed ID: 30802415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting MOR-mGluR
    Shueb SS; Erb SJ; Lunzer MM; Speltz R; Harding-Rose C; Akgün E; Simone DA; Portoghese PS
    Neuropharmacology; 2019 Dec; 160():107690. PubMed ID: 31271770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer pain management and the opioid crisis in America: How to preserve hard-earned gains in improving the quality of cancer pain management.
    Paice JA
    Cancer; 2018 Jun; 124(12):2491-2497. PubMed ID: 29499072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pain Management for Patients With Advanced Cancer in the Opioid Epidemic Era.
    Dalal S; Bruera E
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():24-35. PubMed ID: 31099619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of Opioid Pharmacogenetics and Considerations for Pain Management.
    Owusu Obeng A; Hamadeh I; Smith M
    Pharmacotherapy; 2017 Sep; 37(9):1105-1121. PubMed ID: 28699646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting the risk for aberrant opioid use behavior in patients receiving outpatient supportive care consultation at a comprehensive cancer center.
    Yennurajalingam S; Edwards T; Arthur JA; Lu Z; Najera J; Nguyen K; Manju J; Kuriakose L; Wu J; Liu D; Williams JL; Reddy SK; Bruera E
    Cancer; 2018 Oct; 124(19):3942-3949. PubMed ID: 30192372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of genetic variation on sensitivity to opioid analgesics in patients with postoperative pain: a systematic review and meta-analysis.
    Ren ZY; Xu XQ; Bao YP; He J; Shi L; Deng JH; Gao XJ; Tang HL; Wang YM; Lu L
    Pain Physician; 2015; 18(2):131-52. PubMed ID: 25794200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A low pKa ligand inhibits cancer-associated pain in mice by activating peripheral mu-opioid receptors.
    Baamonde A; Menéndez L; González-Rodríguez S; Lastra A; Seitz V; Stein C; Machelska H
    Sci Rep; 2020 Oct; 10(1):18599. PubMed ID: 33122720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid Prescribing in an Opioid Crisis: What Basic Skills Should an Oncologist Have Regarding Opioid Therapy?
    Arthur J; Reddy A
    Curr Treat Options Oncol; 2019 Apr; 20(5):39. PubMed ID: 30937544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioids in cancer-related pain: current situation and outlook.
    George B; Minello C; Allano G; Maindet C; Burnod A; Lemaire A
    Support Care Cancer; 2019 Aug; 27(8):3105-3118. PubMed ID: 31127436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pain in cancer].
    Fleisch J; Dahan A
    Ned Tijdschr Geneeskd; 2018; 161():D1447. PubMed ID: 29424325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex differences in the response to opioids for pain relief: A systematic review and meta-analysis.
    Pisanu C; Franconi F; Gessa GL; Mameli S; Pisanu GM; Campesi I; Leggio L; Agabio R
    Pharmacol Res; 2019 Oct; 148():104447. PubMed ID: 31499196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safe Opioid Use, Storage, and Disposal Strategies in Cancer Pain Management.
    Reddy A; de la Cruz M
    Oncologist; 2019 Nov; 24(11):1410-1415. PubMed ID: 31097618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.